NTRA

Natera, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$322.94

Price (1 Year)

$414.3 $182.65

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.4 / %30
Non-compliant assets / Total market cap %5 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.

Website

Analysis (Turkish): NTRA Hissesi Caiz mi, Helal mi? Natera, Inc. Katılım Analizi